{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:53:31Z","timestamp":1791201211312,"version":"4.2.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The practice of artificial intelligence has recently expanded several social spheres, with the pharmaceutical domain leading the way. Given that AI can facilitate rational drug design, it is plausible to envision its involvement in developing pharmaceutical products from the laboratory to the patient\u2019s bedside. AI recognizes hit and lead compounds, followed by validation of therapeutic targets and optimization of molecular design. Artificial intelligence significantly impacts drug discovery and development processes, including target identification, molecule design, drug-drug interactions, drug repurposing, optimization of clinical trials, drug toxicity prediction, drug formulation, and delivery. AI-assisted approaches are progressively being employed for identification and prioritization of targets, biomarker discovery and virtual screening as well as prediction for the interaction of protein and ligand and their molecular properties followed by ADMET screening, molecular design and repurposing to be suited for clinical trial optimization. The significance of automation will be boosted by adopting the most recent artificial intelligence-based technologies, reducing the time it takes for drugs to be available in the market with improved quality, production process safety, and resource utilization. The application of artificial intelligence may not only aid in rapid decision-making but can also enhance the process of incorporating the newly discovered drug into the optimum dosage form, which leads to faster manufacturing of higher-quality drugs and ensures consistency among batches. The potential of artificial intelligence in drug discovery and development, has been explored in this review, encircling several stages from identification of target to its clinical applications, followed by drug development approaches encompassing the future of artificial intelligence in the pharmaceutical sector, along with crosstalk on the tools and tactics used to enforce artificial intelligence, current difficulties, and respective solutions<\/jats:p>","DOI":"10.3389\/fonc.2026.1907591","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:01:35Z","timestamp":1791198095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Redefining drug discovery: AI-driven strategies for efficient cancer therapeutics"],"prefix":"10.3389","volume":"16","author":[{"given":"Diptanu","family":"De","sequence":"first","affiliation":[{"name":"Department of Biotechnology, School of Biosciences and Technology Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohini","family":"Chakraborty","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Biosciences and Technology Vellore Institute of Technology","place":["Vellore, India"]},{"name":"Department of Biotechnology, School of Applied Sciences, REVA University","place":["Bengaluru, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satarupa","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Biosciences and Technology Vellore Institute of Technology","place":["Vellore, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/01900692.2018.1498103","article-title":"Artificial intelligence and the public sector\u2014applications and challenges","volume":"42","author":"Wirtz","year":"2019","journal-title":"Int J Public Administration"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0008125619864925","article-title":"A brief history of artificial intelligence: on the past, present, and future of artificial intelligence","volume":"61","author":"Haenlein","year":"2019","journal-title":"California Manage Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1308\/147870804290","article-title":"Artificial intelligence in medicine","volume":"86","author":"Ramesh","year":"2004","journal-title":"Ann R Coll Surgeons Engl"},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1049\/ip-its:20060014","article-title":"The potential application of artificial intelligence in transport","volume":"153","author":"Miles","year":"2006","journal-title":"IEE Proc - Intelligent Transport Syst"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s42256-021-00418-8","article-title":"Geometric deep learning on molecular representations","volume":"3","author":"Atz","year":"2021","journal-title":"Nat Mach Intell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.122498","article-title":"Geometric deep learning for drug discovery","volume":"240","author":"Liu","year":"2024","journal-title":"Expert Syst Appl"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0307","article-title":"An overview of drug discovery and development","volume":"12","author":"Berdigaliyev","year":"2020","journal-title":"Future Med Chem"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.12.011","article-title":"Machine and deep learning approaches for cancer drug repurposing","volume":"68","author":"Issa","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2019.0151","article-title":"Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics","volume":"23","author":"Koromina","year":"2019","journal-title":"OMICS: A J Integr Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104518","article-title":"Foundation models in drug discovery: phenomenal growth today, transformative potential tomorrow","volume":"30","author":"Delile","year":"2025","journal-title":"Drug Discov Today"},{"key":"B11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40593-022-00313-2","article-title":"The intertwined histories of artificial intelligence and education","volume":"33","author":"Doroudi","year":"2023","journal-title":"Int J Artif Intell Educ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nic.2020.07.004","article-title":"Brief history of artificial intelligence","volume":"30","author":"Muthukrishnan","year":"2020","journal-title":"Neuroimaging Clinics North America"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1515\/mr-2023-0023","article-title":"The artificial intelligence pharma era after \u201cChat Generative Pre-trained Transformer","volume":"3","author":"Xie","year":"2023","journal-title":"Med Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.protcy.2013.12.105","article-title":"The electronic health record and its contribution to healthcare information systems interoperability","volume":"9","author":"Jardim","year":"2013","journal-title":"Proc Technol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1177\/0840470419873123","article-title":"Artificial intelligence in healthcare: an essential guide for health leaders","volume":"33","author":"Chen","year":"2020","journal-title":"Healthcare Manage Forum"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/2374289519873088","article-title":"Artificial intelligence and machine learning in pathology: the present landscape of supervised methods","volume":"6","author":"Rashidi","year":"2019","journal-title":"Acad Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.7b01137","article-title":"Adversarial threshold neural computer for molecular de novo design","volume":"15","author":"Lane","year":"2018","journal-title":"Mol Pharmaceutics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.insi.2025.100049","article-title":"Artificial intelligence (AI) in drug design and discovery: a comprehensive review","volume":"1","author":"Bhat","year":"2025","journal-title":"In Silico Res Biomedicine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16101328","article-title":"Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine","volume":"16","author":"Serrano","year":"2024","journal-title":"Pharmaceutics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/medicines12040028","article-title":"AI-driven drug repurposing: applications and challenges","volume":"12","author":"Keramida","year":"2025","journal-title":"Medicines"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhip.2025.03.007","article-title":"The transformative power of artificial intelligence in pharmaceutical manufacturing: enhancing efficiency, product quality, and safety","volume":"6","author":"Rajesh","year":"2025","journal-title":"J Holistic Integr Pharm"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/life15040654","article-title":"Artificial intelligence-powered quality assurance: transforming diagnostics, surgery, and patient care\u2014innovations, limitations, and future directions","volume":"15","author":"Shin","year":"2025","journal-title":"Life"},{"key":"B24","doi-asserted-by":"publisher","first-page":"18911","DOI":"10.1038\/s41598-019-54849-w","article-title":"Improving the odds of drug development success through human genomics: modelling study","volume":"9","author":"Hingorani","year":"2019","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2019.02.005","article-title":"Phase II trials in drug development and adaptive trial design","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC: Basic to Trans Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120554","article-title":"Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future","volume":"602","author":"Arden","year":"2021","journal-title":"Int J Pharm"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1039\/D4PM00323C","article-title":"AI-driven innovations in pharmaceuticals: optimizing drug discovery and industry operations","volume":"2","author":"Saini","year":"2025","journal-title":"RSC Pharmaceutics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"34202","DOI":"10.1038\/s41598-025-15688-0","article-title":"The application of industry 4.0 into the company\u2019s production activities through effective decision-making","volume":"15","author":"Tashkinov","year":"2025","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s44385-024-00003-9","article-title":"Application of artificial intelligence in drug-target interactions prediction: a review","volume":"2","author":"Liao","year":"2025","journal-title":"NPJ Biomed Innov"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17111440","article-title":"Artificial intelligence (AI) in pharmaceutical formulation and dosage calculations","volume":"17","author":"Joshi","year":"2025","journal-title":"Pharmaceutics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"32246","DOI":"10.1038\/s41598-025-14429-7","article-title":"AI edge cloud service provisioning for knowledge management smart applications","volume":"15","author":"Maci\u00e1-Lillo","year":"2025","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15110503","article-title":"Digital twins in personalized medicine: bridging innovation and clinical reality","volume":"15","author":"Silva","year":"2025","journal-title":"J Personalized Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ipha.2024.02.009","article-title":"Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry","volume":"2","author":"Yadav","year":"2024","journal-title":"Intelligent Pharm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/minf.202100321","article-title":"Benchmarking accuracy and generalizability of four graph neural networks using large in vitro ADME datasets from different chemical spaces","volume":"41","author":"Broccatelli","year":"2022","journal-title":"Mol Inf"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2026.111481","article-title":"Graph neural network-guided identification and biological evaluation of potential AKT1 inhibitors for triple-negative breast cancer","volume":"203","author":"Jaiswal","year":"2026","journal-title":"Comput Biol Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3769677","article-title":"Structure-based drug design with geometric deep learning: A comprehensive survey","volume":"58","author":"Zhang","year":"2026","journal-title":"ACM Comput Surv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1458739","article-title":"Large language models facilitating modern molecular biology and novel drug development","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"020050","DOI":"10.1063\/1.5132477","article-title":"Random forest for breast cancer prediction","author":"Octaviani","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8322","DOI":"10.1038\/s41598-018-25947-y","article-title":"Linking drug target and pathway activation for effective therapy using multi-task learning","volume":"8","author":"Yang","year":"2018","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/risks11090160","article-title":"Fraud detection in healthcare insurance claims using machine learning","volume":"11","author":"Nabrawi","year":"2023","journal-title":"Risks"},{"key":"B41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jpba.2005.01.035","article-title":"Study of probabilistic neural networks to classify the active compounds in medicinal plants","volume":"38","author":"Xue","year":"2005","journal-title":"J Pharm BioMed Anal"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eij.2012.08.002","article-title":"Support vector machines (SVMs) versus multilayer perception (MLP) in data classification","volume":"13","author":"Zanaty","year":"2012","journal-title":"Egypt Inf J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4137\/GRSB.S702","article-title":"Centrality analysis methods for biological networks and their application to gene regulatory networks","volume":"2","author":"Kosch\u00fctzki","year":"2008","journal-title":"Gene Regul Syst Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2023.1124553","article-title":"Decision trees: from efficient prediction to responsible AI","volume":"6","author":"Blockeel","year":"2023","journal-title":"Front Artif Intell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.998388","article-title":"Anti-cancer immune responses to DNA damage response inhibitors: molecular mechanisms and progress toward clinical translation","volume":"12","author":"Carlsen","year":"2022","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.06.010","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","article-title":"Artificial intelligence in cancer target identification and drug discovery","volume":"7","author":"You","year":"2022","journal-title":"Signal Transduction Targeted Ther"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1039\/D2SC05709C","article-title":"AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor","volume":"14","author":"Ren","year":"2023","journal-title":"Chem Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-021-00161-0","article-title":"What does AlphaFold mean for drug discovery","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.03.006","article-title":"Structure-based drug repurposing: traditional and advanced AI\/ML-aided methods","volume":"27","author":"Choudhury","year":"2022","journal-title":"Drug Discov Today"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-024-00548-5","article-title":"Advances in artificial intelligence-based technologies for increasing the quality of medical products","volume":"33","author":"Srivastava","year":"2024","journal-title":"DARU J Pharm Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5c00641","article-title":"Generative deep learning for de novo drug design\u2500a chemical space odyssey","volume":"65","author":"\u00d6z\u00e7elik","year":"2025","journal-title":"J Chem Inf Model"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23102520","article-title":"Artificial intelligence in drug design","volume":"23","author":"Hessler","year":"2018","journal-title":"Molecules"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109148","article-title":"Drug-drug interactions prediction based on deep learning and knowledge graph: a review","volume":"27","author":"Luo","year":"2024","journal-title":"IScience"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/169852","article-title":"Identifying drug interactions using machine learning","volume":"32","author":"Demirsoy","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12859-019-3013-0","article-title":"Novel deep learning model for more accurate prediction of drug-drug interaction effects","volume":"20","author":"Lee","year":"2019","journal-title":"BMC Bioinf"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105119","article-title":"Clinical relevance and methodological approach for the assessment of drug\u2013drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF)","volume":"10","author":"Del Re","year":"2025","journal-title":"ESMO Open"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.908549","article-title":"An integrative heterogeneous graph neural network\u2013based method for multi-labeled drug repurposing","volume":"13","author":"Sadeghi","year":"2022","journal-title":"Front Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/pst.2430","article-title":"Quality by design for preclinical in vitro assay development","volume":"24","author":"Jones","year":"2025","journal-title":"Pharm Stat"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1039\/C9SC04336E","article-title":"Target identification among known drugs by deep learning from heterogeneous networks","volume":"11","author":"Zeng","year":"2020","journal-title":"Chem Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105419","article-title":"Repurposing of HIV\/HCV protease inhibitors against SARS-CoV-2 3CLpro","volume":"207","author":"Ma","year":"2022","journal-title":"Antiviral Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz519","article-title":"KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules","volume":"35","author":"Li","year":"2019","journal-title":"Bioinformatics"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/med.21764","article-title":"Artificial intelligence and machine learning\u2010aided drug discovery in central nervous system diseases: State\u2010of\u2010the\u2010arts and future directions","volume":"41","author":"Vatansever","year":"2021","journal-title":"Med Res Rev"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1331062","article-title":"Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities","volume":"15","author":"Gangwal","year":"2024","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2415665122","article-title":"Generative AI for navigating synthesizable chemical space","volume":"122","author":"Gao","year":"2025","journal-title":"Proc Natl Acad Sci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.124180","article-title":"Advances in AI for predicting pharmacological properties of natural medicines","volume":"387","author":"Xu","year":"2026","journal-title":"Life Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1021\/ci400187y","article-title":"Deep architectures and deep learning in chemoinformatics: the prediction of aqueous solubility for drug-like molecules","volume":"53","author":"Lusci","year":"2013","journal-title":"J Chem Inf Model"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.9b00237","article-title":"Analyzing learned molecular representations for property prediction","volume":"59","author":"Yang","year":"2019","journal-title":"J Chem Inf Model"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fenvs.2015.00080","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front Environ Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22020279","article-title":"Drug design and discovery: Principles and applications","volume":"22","author":"Zhou","year":"2017","journal-title":"Molecules"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110032","article-title":"Predicting therapeutic and side effects from drug binding affinities to human proteome structures","volume":"27","author":"Sawada","year":"2024","journal-title":"IScience"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.compchemeng.2023.108403","article-title":"Graph neural networks with molecular segmentation for property prediction and structure\u2013property relationship discovery","volume":"179","author":"Chen","year":"2023","journal-title":"Comput Chem Eng"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.70011","article-title":"Mfgnn: Multi\u2010scale feature\u2010attentive graph neural networks for molecular property prediction","volume":"46","author":"Ye","year":"2025","journal-title":"J Comput Chem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/acs.jcim.2c01099","article-title":"HiGNN: A hierarchical informative graph neural network for molecular property prediction equipped with feature-wise attention","volume":"63","author":"Zhu","year":"2023","journal-title":"J Chem Inf Model"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2025.100223","article-title":"Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction","volume":"28","author":"Pathan","year":"2025","journal-title":"Med Drug Discov"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16060776","article-title":"Predicting ADMET properties from molecule SMILE: a bottom-up approach using attention-based graph neural networks","volume":"16","author":"De Carlo","year":"2024","journal-title":"Pharmaceutics"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c01139","article-title":"Conformalized graph learning for molecular ADMET property prediction and reliable uncertainty quantification","volume":"64","author":"Li","year":"2024","journal-title":"J Chem Inf Model"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty593","article-title":"DeepDTA: deep drug\u2013target binding affinity prediction","volume":"34","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Bioinformatics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1038\/s41467-025-59874-0","article-title":"Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors","volume":"16","author":"Pu","year":"2025","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2025.108865","article-title":"USP1 inhibition: A journey from target discovery to clinical translation","volume":"271","author":"Torrado","year":"2025","journal-title":"Pharmacol Ther"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1538-7445.AM2024-1656","article-title":"Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1158\/1538-7445.AM2025-5723","article-title":"Abstract 5723: XL309 is a potent, selective, and orally bioavailable USP1 inhibitor active as monotherapy and in combination with PARP inhibitors or irinotecan","volume":"85","author":"Charruyer-Reinwald","year":"2025","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1158\/1538-7445.AM2023-502","article-title":"Abstract 502: ISM3091, a novel selective USP1 inhibitor as a targeted anticancer therapy","volume":"83","author":"Li","year":"2023","journal-title":"Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1158\/1538-7445.AM2023-503","article-title":"Abstract 503: ISM3412, a novel and selective MAT2A inhibitor for the treatment of cancer","volume":"83","author":"Meng","year":"2023","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S201","DOI":"10.1016\/j.annonc.2023.09.1547","article-title":"45P therapeutic potential of ISM8207: a novel QPCTL inhibitor, in triple-negative breast cancer and B-cell non-Hodgkin lymphoma","volume":"34","author":"Rao","year":"2023","journal-title":"Ann Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-CT114","article-title":"Abstract CT114: Data from first-in-human study of EXS21546, an A2A receptor antagonist, now progressing into phase 1 in RCC\/NSCLC","volume":"83","author":"Diaz","year":"2023","journal-title":"Cancer Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1158\/1538-7445.AM2021-1731","article-title":"Abstract 1731: EXS21546, a non-CNS penetrant A2AR-selective antagonist for anti-cancer immunotherapy","volume":"81","author":"Payne","year":"2021","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1158\/1538-7445.AM2022-3930","article-title":"Abstract 3930: AI-driven discovery and profiling of GTAEXS-617, a selective and highly potent inhibitor of CDK7","volume":"82","author":"Besnard","year":"2022","journal-title":"Cancer Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03743-2","article-title":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial","volume":"31","author":"Xu","year":"2025","journal-title":"Nat Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104009","article-title":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","volume":"29","author":"KP Jayatunga","year":"2024","journal-title":"Drug Discov Today"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.027","article-title":"Looking beyond the hype: Applied AI and machine learning in translational medicine","volume":"47","author":"Toh","year":"2019","journal-title":"EBioMedicine"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02730-z","article-title":"The role of data science in healthcare advancements: applications, benefits, and future prospects","volume":"191","author":"Subrahmanya","year":"2022","journal-title":"Irish J Med Sci (1971 -)"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413405","article-title":"Machine learning\u2010enabled drug\u2010induced toxicity prediction","volume":"12","author":"Bai","year":"2025","journal-title":"Adv Sci"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13142379","article-title":"Histopathological images analysis and predictive modeling implemented in digital pathology\u2014current affairs and perspectives","volume":"13","author":"Moscalu","year":"2023","journal-title":"Diagnostics"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101533","article-title":"Deep learning for small-molecule drug discovery: from molecular design to clinical translation","volume":"16","author":"Oliveira","year":"2026","journal-title":"J Pharm Anal"},{"key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s43246-022-00315-6","article-title":"Graph neural networks for materials science and chemistry","volume":"3","author":"Reiser","year":"2022","journal-title":"Commun Mater"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/minf.70047","article-title":"Geometric deep learning\u2010based drug design models for small\u2010molecule drug discovery","volume":"45","author":"Srivastav","year":"2026","journal-title":"Mol Inf"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2025.100213","article-title":"Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science","volume":"27","author":"Das","year":"2025","journal-title":"Med Drug Discov"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae006","article-title":"Multimodal transformers and their applications in drug target discovery for aging and age-related diseases","volume":"79","author":"Steurer","year":"2024","journal-title":"Journals Gerontology Ser A Biol Sci Med Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbag245","article-title":"The next paradigm in bioinformatics: a review of multi-agent systems and foundational models for end-to-end scientific discovery","volume":"27","author":"Branda","year":"2026","journal-title":"Briefings Bioinf"},{"key":"B105","doi-asserted-by":"publisher","first-page":"10752","DOI":"10.1038\/s41598-019-47148-x","article-title":"Optimization of molecules via deep reinforcement learning","volume":"9","author":"Zhou","year":"2019","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2026.104679","article-title":"Physics-inspired explainable AI for mechanistic and decision support in drug discovery","volume":"31","author":"Lavecchia","year":"2026","journal-title":"Drug Discov Today"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000705","article-title":"Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs","volume":"109","author":"Chopra","year":"2023","journal-title":"Int J Surg"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106938","article-title":"Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance","volume":"203","author":"Huanbutta","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1177\/20420986251361435","article-title":"Artificial intelligence in pharmacovigilance: advancing drug safety monitoring and regulatory integration","volume":"16","author":"Nagar","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2206","article-title":"Controlled drug release by a nanorobot","volume":"30","author":"Fu","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/frobt.2025.1639445","article-title":"Nano bio-robots: a new frontier in targeted therapeutic delivery","volume":"12","author":"Anto","year":"2025","journal-title":"Front Rob AI"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907591\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:01:37Z","timestamp":1791198097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1907591\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":111,"alternative-id":["10.3389\/fonc.2026.1907591"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1907591","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1907591"}}